Hospital de Clinicas de Porto Alegre-HCPA

Porto Alegre, Rio Grande do Sul 90035-903/90035-003

4 studies enrolling now · 10 studies all time

What they study most

Biliary Tract Cancer, Crohn's Disease, Dermatitis, Atopic, Gastric Cancer, Gastroesophageal-junction Cancer, Gaucher Disease, Gaucher Disease, Type 1, HER2-positive Gastric Cancer, Monoclonal Antibody, Osteogenesis Imperfecta, Prostate Cancer, Ulcerative Colitis

Studies at this site

• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — Recruiting now
• A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED) — Recruiting now
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now
• Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta — Running, not enrolling
• Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis — Completed
• A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer — Completed
• Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis — Completed
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis — Completed
• A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis — Completed